Driving Improved Outcomes in Resectable Melanoma: Pathways for Optimized Adjuvant Immunotherapy Strategies

Share

Program Content

Activities

  • Melanoma Adjuvant Immunotherapy
    Driving Improved Outcomes in Resectable Melanoma: Pathways for Optimized Adjuvant Immunotherapy Strategies
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 28, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with AIM at Melanoma Foundation.

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Partners

AIM at Melanoma Foundation

ProCE Banner